Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxervate in Stage 1 neurotrophic keratitis
NCT04485546Phase 4Completed
- Sponsor
- Dompé
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of cenegermin in neurotrophic keratitis (NK), sponsored by Dompé. Started Sep 2020; status: completed.
02
Drugs
cenegermin
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT04485546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485546.